SCHEMBL1675356

SCHEMBL1675356

CCNC(=O)c1ccc(-c2ccc3ncnc(NCCc4c[nH]cn4)c3c2)o1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 16/20 0.49
CLK1 P49759 5/20 0.49
CLK2 P49760 5/20 0.49
DYRK1B Q9Y463 5/20 0.49
DYRK1A Q13627 4/20 0.49
ALDH1A1 P00352 10/20 0.43
CYP1A2 P05177 10/20 0.43
CYP3A4 P08684 9/20 0.43
HSD17B10 Q99714 9/20 0.43
CYP2D6 P10635 7/20 0.43
USP2 O75604 6/20 0.43
CYP2C19 P33261 6/20 0.43
LMNA P02545 4/20 0.43
TSHR P16473 3/20 0.41
HIF1A Q16665 4/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
CYP2C9 P11712 2/20 0.41
CDK1 P06493 2/20 0.41
TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675093 0.89 CLK4 (0.61) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675185 0.87 CLK4 (0.65) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675270 0.82 CLK4 (0.60) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675497 0.81 CLK4 (0.45) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675232 0.80 CLK4 (0.66) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675287 0.78 CLK4 (0.79) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675128 0.76 CLK4 (0.61) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675219 0.75 CLK4 (0.57) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675111 0.75 CLK4 (0.57) CLK4CLK1CLK2DYRK1BDYRK1A
SCHEMBL1675360 0.74 CLK4 (0.57) CLK4ALDH1A1CYP1A2CYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed